Literature DB >> 8883415

mdm2 gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line.

S Kondo1, Y Kondo, H Hara, R Kaakaji, J W Peterson, T Morimura, J Takeuchi, G H Barnett.   

Abstract

The overexpression of the multidrug resistance (mdr1) gene and its product, P-glycoprotein (P-gp), is thought to limit the successful chemotherapy of human tumours. The mechanism by which mdr1 gene and P-gp are overexpressed in human tumours, however, is not yet clear. In this report, we show that the mdm2 (murine double minute 2) gene induced the expression of the mdr1 gene and P-gp in human glioblastoma U87-MG cells, which did not express the MDM2 protein or P-gp. The mdm2 gene, in addition, conferred the resistance of U87-MG cells to the apoptotic cell death induced by etoposide (VP-16) or doxorubicin. Furthermore, treatment with mdm2 antisense oligonucleotides inhibited the expression of P-gp in MDM2-expressing U87-MG cells. These findings suggest that the mdm2 gene may play an important role in the development of MDR phenotype in human tumours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883415      PMCID: PMC2075914          DOI: 10.1038/bjc.1996.527

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Expression of a multidrug-resistance gene in human tumors and tissues.

Authors:  A T Fojo; K Ueda; D J Slamon; D G Poplack; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

2.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

Authors:  R L Juliano; V Ling
Journal:  Biochim Biophys Acta       Date:  1976-11-11

3.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.

Authors:  K Ueda; C Cardarelli; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells.

Authors:  I B Roninson; H T Abelson; D E Housman; N Howell; A Varshavsky
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

6.  Isolation and expression of a complementary DNA that confers multidrug resistance.

Authors:  P Gros; Y B Ben Neriah; J M Croop; D E Housman
Journal:  Nature       Date:  1986 Oct 23-29       Impact factor: 49.962

7.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

8.  Expression of a multidrug resistance gene in human cancers.

Authors:  L J Goldstein; H Galski; A Fojo; M Willingham; S L Lai; A Gazdar; R Pirker; A Green; W Crist; G M Brodeur
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

9.  Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells.

Authors:  A R Safa; C J Glover; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1986-05-15       Impact factor: 5.157

10.  Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia.

Authors:  D D Ma; R D Scurr; R A Davey; S M Mackertich; D H Harman; G Dowden; J P Isbister; D R Bell
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

View more
  11 in total

1.  Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53.

Authors:  J C Senturk; S Bohlman; J J Manfredi
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

2.  Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.

Authors:  D S Tews; A Nissen; C Külgen; A K Gaumann
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

3.  Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer.

Authors:  Zhenfeng Duan; Edward J Weinstein; Diana Ji; Rachel Y Ames; Edwin Choy; Henry Mankin; Francis J Hornicek
Journal:  Mol Cancer Ther       Date:  2008-08-07       Impact factor: 6.261

4.  Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.

Authors:  Stella M Ranuncolo; Mirta Varela; Ana Morandi; José Lastiri; Silvia Christiansen; Elisa Bal de Kier Joffé; María G Pallotta; Lydia Puricelli
Journal:  J Neurooncol       Date:  2004-06       Impact factor: 4.130

5.  Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.

Authors:  H A Cocker; C R Pinkerton; L R Kelland
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

6.  High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance.

Authors:  H A Cocker; S M Hobbs; N Tiffin; K Pritchard-Jones; C R Pinkerton; L R Kelland
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

7.  Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma.

Authors:  A Suzuki; M Toi; Y Yamamoto; S Saji; M Muta; T Tominaga
Journal:  Jpn J Cancer Res       Date:  1998-02

8.  Efficacy of D,L-methadone in the treatment of glioblastoma in vitro.

Authors:  Konstantin Brawanski; Gero Brockhoff; Peter Hau; Arabel Vollmann-Zwerenz; Christian Freyschlag; Annette Lohmeier; Markus J Riemenschneider; Claudius Thomé; Alexander Brawanski; Martin A Proescholdt
Journal:  CNS Oncol       Date:  2018-06-19

9.  Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system.

Authors:  Elvis Terci Valera; Agda Karina Brodoloni Lucio-Eterovic; Luciano Neder; Carlos Alberto Scrideli; Helio Rubens Machado; Carlos Gilberto Carlotti-Junior; Rosane Gomes de Paula Queiroz; Fabio José do Nascimento Motta; Luiz Gonzaga Tone
Journal:  J Neurooncol       Date:  2007-04-12       Impact factor: 4.506

10.  A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin.

Authors:  H-J Tang; D Qian; V K Sondak; S Stachura; J Lin
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.